Apotheek Ramaekers SRL

Apotheek Ramaekers reported total assets of 709,441 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Aug 2026).

Company number (CBE) 0878.166.140 · VAT BE0878166140
3620 Lanaken
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 23 Dec 2005 (≈ 21 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Apotheek Ramaekers shows with a free account.

See the score
Profile
SRL since 2005
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result113,800 €
Equity66,748 €
Cash31,304 €
EBITDA170,752 €
Total assets709,441 €
The line marks its sector median: 44.2% (2068 companies).

Change 2022 → 2025: Equity +35 % Total assets +13 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Apotheek Ramaekers's annual accounts

20252024202320222021
Net result113,800 €
Equity66,748 €
Cash31,304 €
EBITDA170,752 €
Total assets709,441 €

Filed annual accounts

  • Year ended 31 Dec 2025filed on 06 Aug 2026
  • Year ended 31 Dec 2024filed on 11 Aug 2025
  • Year ended 31 Dec 2023filed on 19 Jul 2024
  • Year ended 31 Dec 2022filed on 14 Jul 2023
  • Year ended 31 Dec 2021filed on 26 Jul 2022

Apotheek Ramaekers's financial analysis

Management and control of Apotheek Ramaekers

2 active director(s) in the register.

Apotheek Ramaekers's shareholders and holdings →

Apotheek Ramaekers's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0878.166.140
VAT number
BE0878166140
Peppol
Registered · 0208:0878166140 · as of 10 Nov 2026
Legal form
SRL
Incorporated
23 Dec 2005
Registered office
3620 Lanaken
Latest accounts
2025 · filed on 06 Aug 2026
Activity
Retail sale of pharmaceutical products (NACE 47730)

Apotheek Ramaekers (SRL) has been based in Lanaken since 2005, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 113,800 € and equity of 66,748 €; its revenue is not published.

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Apotheek Ramaekers

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Apotheek Ramaekers

What is the revenue of Apotheek Ramaekers?

Apotheek Ramaekers files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Apotheek Ramaekers?

In Belgium, the VAT number is the company number prefixed with BE: BE0878166140 for Apotheek Ramaekers, if the company is VAT-registered. Its company number (CBE) is 0878.166.140.

Where is the registered office of Apotheek Ramaekers?

According to the CBE register, the registered office of Apotheek Ramaekers is in 3620 Lanaken.

What is the equity of Apotheek Ramaekers?

At the close of the 2025 financial year, the equity of Apotheek Ramaekers amounts to 66,748 €, a solvency of 9.4% of total assets.

Who manages Apotheek Ramaekers?

The register lists 2 active mandates at Apotheek Ramaekers. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Apotheek Ramaekers

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 03 Sep 2026

No credit card, no commitment.

What each plan unlocks →